Hypera (BSP:HYPE3) Days Sales Outstanding : 147.24 (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Hypera Days Sales Outstanding?

Hypera's average Accounts Receivable for the three months ended in Mar. 2025 was R$1,744 Mil. Hypera's Revenue for the three months ended in Mar. 2025 was R$1,081 Mil. Hence, Hypera's Days Sales Outstanding for the three months ended in Mar. 2025 was 147.24.

The historical rank and industry rank for Hypera's Days Sales Outstanding or its related term are showing as below:

BSP:HYPE3' s Days Sales Outstanding Range Over the Past 10 Years
Min: 105.27 Med: 119.62 Max: 153.49
Current: 134.29

During the past 13 years, Hypera's highest Days Sales Outstanding was 153.49. The lowest was 105.27. And the median was 119.62.

BSP:HYPE3's Days Sales Outstanding is ranked worse than
84.62% of 949 companies
in the Drug Manufacturers industry
Industry Median: 72.66 vs BSP:HYPE3: 134.29

Hypera's Days Sales Outstanding increased from Mar. 2024 (134.18) to Mar. 2025 (147.24).

Hypera Days Sales Outstanding Historical Data

The historical data trend for Hypera's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Days Sales Outstanding Chart

Hypera Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

128.46

110.77

110.55

119.30

119.94

Hypera Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															134.18	121.69	145.30	158.30	147.24

Competitive Comparison of Hypera's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypera's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hypera's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Hypera Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hypera's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (2642.146	+	2249.259)	/	2 )	/	7442.466	*	365
=	2445.7025					/	7442.466	*	365
=	119.94

Hypera's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (2249.259	+	1238.95)	/	2 )	/	1080.906	*	365 / 4
=	1744.1045					/	1080.906	*	365 / 4
=	147.24

Hypera (BSP:HYPE3) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hypera Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hypera's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

HYPMY:USA

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and the Non-Retail Market.

Hypera Headlines

No Headlines